盐酸替拉凡星
Tier C — Watch / tradeTelavancin Hydrochloride
Targets:Peptidoglycan
Brand:Arbelic、Vibativ
Indications (approved):呼吸机相关性肺炎、细菌性肺炎、医院获得性肺炎、医疗保健相关性肺炎、复杂皮肤和皮肤结构感染
Regional status
Synthetic routes & intermediates3 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

| Code | CAS No. | Intermediate |
|---|---|---|
| TELA-001 | 5196-28-8 | 2-(decylamino)ethan-1-ol |
| TELA-002 | 239088-19-8 | (9H-fluoren-9-yl)methyl decyl(2-hydroxyethyl)carbamate |
| TELA-003 | 239088-22-3 | (9H-fluoren-9-yl)methyl decyl(2-oxoethyl)carbamate |
| TELA-004 | 1404-90-6 | Vancomycin |
| TELA-005 | 281229-92-3 | Vancomycin, N3''-[2-[decyl[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]- |
| TELA-006 | 281226-43-5 | Vancomycin, N3''-[2-(decylamino)ethyl]- |
| TELA-007 | 1066-51-9 | (aminomethyl)phosphonic acid |

| Code | CAS No. | Intermediate |
|---|---|---|
| TELA-003 | 239088-22-3 | (9H-fluoren-9-yl)methyl decyl(2-oxoethyl)carbamate |
| TELA-004 | 1404-90-6 | Vancomycin |
| TELA-007 | 1066-51-9 | (aminomethyl)phosphonic acid |
| TELA-008 | 1426831-63-1 | Vancomycin, N3''-[2-[decyl[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethylidene]- |
| TELA-009 | 1426831-64-2 | Vancomycin, N3''-[2-[decyl[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethylidene]-29-[[(phosphonomethyl)amino]methyl]- |

| Code | CAS No. | Intermediate |
|---|---|---|
| TELA-003 | 239088-22-3 | (9H-fluoren-9-yl)methyl decyl(2-oxoethyl)carbamate |
| TELA-004 | 1404-90-6 | Vancomycin |
| TELA-005 | 281229-92-3 | Vancomycin, N3''-[2-[decyl[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]- |
| TELA-007 | 1066-51-9 | (aminomethyl)phosphonic acid |
| TELA-008 | 1426831-63-1 | Vancomycin, N3''-[2-[decyl[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethylidene]- |
| TELA-010 | 1426832-37-2 | Vancomycin, N3''-[2-[decyl[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]-29-[[(phosphonomethyl)amino]methyl]- |
Frequently asked questions
What are the approved indications of Telavancin Hydrochloride?
Approved indications include: 呼吸机相关性肺炎, 细菌性肺炎, 医院获得性肺炎, 医疗保健相关性肺炎, 复杂皮肤和皮肤结构感染.
When does the Telavancin Hydrochloride patent expire?
No public expiry year is available for Telavancin Hydrochloride yet; this page updates once verified.
How many synthesis routes are recorded for Telavancin Hydrochloride?
3 synthesis routes are recorded; the shortest is 3 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Telavancin Hydrochloride intermediates?
All intermediates in Telavancin Hydrochloride routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Telavancin Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24